Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease

Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy

(2015) Raffaella Franciotti et al.   MOVEMENT DISORDERS

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

(2015) Thomas G. Beach et al.   NEUROPATHOLOGY

Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein

(2015) Eduard Bentea et al.   Frontiers in Behavioral Neuroscience

The default mode network is disrupted in parkinson's disease with visual hallucinations

(2014) Nailin Yao et al.   HUMAN BRAIN MAPPING

The spectrum of cognitive impairment in Lewy body diseases

(2014) Jennifer G. Goldman et al.   MOVEMENT DISORDERS

The neurobiological basis of cognitive impairment in Parkinson's disease

(2014) Glenda M. Halliday et al.   MOVEMENT DISORDERS

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

(2014) C. H. Adler et al.   NEUROLOGY

α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation

(2014) Jacqueline Burré et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease

(2014) Marta Swirski et al.   Alzheimers Research & Therapy

Power spectra for screening parkinsonian patients for mild cognitive impairment

(2014) Habib Bousleiman et al.   Annals of Clinical and Translational Neurology

Disrupted brain network topology in Parkinson’s disease: a longitudinal magnetoencephalography study

(2013) Kim T. E. Olde Dubbelink et al.   BRAIN

The role of the posterior cingulate cortex in cognition and disease

(2013) Robert Leech et al.   BRAIN

Resting-State Networks in Alzheimer's Disease and Parkinson's Disease

(2013) Irena Rektorova   Neurodegenerative Diseases

Pathophysiology of Parkinson's disease behavior – a view from the network

(2013) John N. Caviness   PARKINSONISM & RELATED DISORDERS

Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study

(2013) Kim T.E. Olde Dubbelink et al.   NeuroImage-Clinical

Biochemical Increase in Phosphorylated Alpha-Synuclein Precedes Histopathology of Lewy-Type Synucleinopathies

(2012) Lih-Fen Lue et al.   BRAIN PATHOLOGY

Dementia, Mild Cognitive Impairment and Quantitative EEG in Patients with Parkinson's Disease

(2012) L.C. Fonseca et al.   CLINICAL EEG AND NEUROSCIENCE

Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains

(2012) Douglas G. Walker et al.   EXPERIMENTAL NEUROLOGY

Accumulation of Toxic  -Synuclein Oligomer within Endoplasmic Reticulum Occurs in  -Synucleinopathy In Vivo

(2012) E. Colla et al.   JOURNAL OF NEUROSCIENCE

Endoplasmic Reticulum Stress Is Important for the Manifestations of  -Synucleinopathy In Vivo

(2012) E. Colla et al.   JOURNAL OF NEUROSCIENCE

α-Synuclein Oligomers: an Amyloid Pore?

(2012) Martin T. Stöckl et al.   MOLECULAR NEUROBIOLOGY

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Biophysics of α-synuclein membrane interactions

(2011) Candace M. Pfefferkorn et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease

(2011) Arianna Bellucci et al.   BRAIN RESEARCH

Grey matter atrophy in cognitively impaired Parkinson's disease

(2011) Tracy R Melzer et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Parkinson's disease, cortical dysfunction, and alpha-synuclein

(2011) John N. Caviness et al.   MOVEMENT DISORDERS

Quantitative EEG as a predictive biomarker for Parkinson disease dementia

(2011) B. T. Klassen et al.   NEUROLOGY

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease

(2010) Pablo Garcia-Reitböck et al.   BRAIN

Parkinson's Disease Dementia and Potential Therapeutic Strategies

(2010) John N. Caviness et al.   CNS Neuroscience & Therapeutics

 -Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

(2010) J. Burre et al.   SCIENCE

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

(2009) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Parkinson Disease With Dementia

(2009) Marwan N. Sabbagh et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Neuropathology of non-motor features of Parkinson disease

(2009) Dennis W. Dickson et al.   PARKINSONISM & RELATED DISORDERS

Comparison of Quantitative EEGs Between Parkinson Disease and Age-Adjusted Normal Controls

(2008) Kan Serizawa et al.   JOURNAL OF CLINICAL NEUROPHYSIOLOGY

Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies

(2007) Kimiko Obi et al.   EXPERIMENTAL NEUROLOGY